Annual D&A
$6.83 M
+$2.43 M+55.25%
December 31, 2023
Summary
- As of February 7, 2025, AXSM annual depreciation & amortization is $6.83 million, with the most recent change of +$2.43 million (+55.25%) on December 31, 2023.
- During the last 3 years, AXSM annual D&A has risen by +$6.76 million (+8695.37%).
- AXSM annual D&A is now at all-time high.
Performance
AXSM Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$2.06 M
+$68.00 K+3.41%
September 30, 2024
Summary
- As of February 7, 2025, AXSM quarterly depreciation & amortization is $2.06 million, with the most recent change of +$68.00 thousand (+3.41%) on September 30, 2024.
- Over the past year, AXSM quarterly D&A has increased by +$321.00 thousand (+18.45%).
- AXSM quarterly D&A is now at all-time high.
Performance
AXSM Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$7.63 M
+$318.00 K+4.35%
September 30, 2024
Summary
- As of February 7, 2025, AXSM TTM depreciation & amortization is $7.63 million, with the most recent change of +$318.00 thousand (+4.35%) on September 30, 2024.
- Over the past year, AXSM TTM D&A has increased by +$791.00 thousand (+11.57%).
- AXSM TTM D&A is now at all-time high.
Performance
AXSM TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
AXSM Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +55.3% | +18.4% | +11.6% |
| 3 y3 years | +8695.4% | +587.7% | +738.5% |
| 5 y5 years | +10000.0% | +10000.0% | +10000.0% |
AXSM Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +8892.1% | at high | +366.9% | at high | +9946.1% |
| 5 y | 5-year | at high | >+9999.0% | at high | +366.9% | at high | >+9999.0% |
| alltime | all time | at high | >+9999.0% | at high | +366.9% | at high | >+9999.0% |
Axsome Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $2.06 M(+3.4%) | $7.63 M(+4.4%) |
| Jun 2024 | - | $1.99 M(+8.8%) | $7.31 M(+4.3%) |
| Mar 2024 | - | $1.83 M(+5.2%) | $7.00 M(+2.5%) |
| Dec 2023 | $6.83 M(+55.2%) | $1.74 M(-0.2%) | $6.83 M(+0.7%) |
| Sep 2023 | - | $1.74 M(+3.2%) | $6.79 M(+0.9%) |
| Jun 2023 | - | $1.69 M(+1.6%) | $6.72 M(+16.9%) |
| Mar 2023 | - | $1.66 M(-1.8%) | $5.75 M(+30.7%) |
| Dec 2022 | $4.40 M(+5692.1%) | $1.69 M(+0.7%) | $4.40 M(+127.2%) |
| Sep 2022 | - | $1.68 M(+134.0%) | $1.94 M(+247.6%) |
| Jun 2022 | - | $718.00 K(+130.1%) | $557.40 K(+377.2%) |
| Mar 2022 | - | $312.00 K(-140.4%) | $116.80 K(+53.9%) |
| Dec 2021 | $76.00 K(-2.2%) | -$772.30 K(-357.7%) | $75.90 K(-91.7%) |
| Sep 2021 | - | $299.70 K(+8.0%) | $909.40 K(+47.8%) |
| Jun 2021 | - | $277.40 K(+2.3%) | $615.20 K(+79.2%) |
| Mar 2021 | - | $271.10 K(+343.0%) | $343.30 K(+342.4%) |
| Dec 2020 | $77.70 K(+108.3%) | $61.20 K(+1012.7%) | $77.60 K(+256.0%) |
| Sep 2020 | - | $5500.00(0.0%) | $21.80 K(-15.2%) |
| Jun 2020 | - | $5500.00(+1.9%) | $25.70 K(-17.9%) |
| Mar 2020 | - | $5400.00(0.0%) | $31.30 K(-16.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | $37.30 K(-23.7%) | $5400.00(-42.6%) | $37.30 K(-15.4%) |
| Sep 2019 | - | $9400.00(-15.3%) | $44.10 K(-7.7%) |
| Jun 2019 | - | $11.10 K(-2.6%) | $47.80 K(-1.2%) |
| Mar 2019 | - | $11.40 K(-6.6%) | $48.40 K(-1.0%) |
| Dec 2018 | $48.90 K(+14.8%) | $12.20 K(-6.9%) | $48.90 K(+1.9%) |
| Sep 2018 | - | $13.10 K(+12.0%) | $48.00 K(+5.0%) |
| Jun 2018 | - | $11.70 K(-1.7%) | $45.70 K(+2.9%) |
| Mar 2018 | - | $11.90 K(+5.3%) | $44.40 K(+4.2%) |
| Dec 2017 | $42.60 K(+107.8%) | $11.30 K(+4.6%) | $42.60 K(+3.6%) |
| Sep 2017 | - | $10.80 K(+3.8%) | $41.10 K(+14.5%) |
| Jun 2017 | - | $10.40 K(+3.0%) | $35.90 K(+26.0%) |
| Mar 2017 | - | $10.10 K(+3.1%) | $28.50 K(+39.0%) |
| Dec 2016 | $20.50 K(+485.7%) | $9800.00(+75.0%) | $20.50 K(+70.8%) |
| Sep 2016 | - | $5600.00(+86.7%) | $12.00 K(+60.0%) |
| Jun 2016 | - | $3000.00(+42.9%) | $7500.00(+38.9%) |
| Mar 2016 | - | $2100.00(+61.5%) | $5400.00(+50.0%) |
| Dec 2015 | $3500.00 | $1300.00(+18.2%) | $3600.00(+56.5%) |
| Sep 2015 | - | $1100.00(+22.2%) | $2300.00(+91.7%) |
| Jun 2015 | - | $900.00(+200.0%) | $1200.00(+300.0%) |
| Mar 2015 | - | $300.00 | $300.00 |
FAQ
- What is Axsome Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Axsome Therapeutics?
- What is Axsome Therapeutics annual D&A year-on-year change?
- What is Axsome Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Axsome Therapeutics?
- What is Axsome Therapeutics quarterly D&A year-on-year change?
- What is Axsome Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Axsome Therapeutics?
- What is Axsome Therapeutics TTM D&A year-on-year change?
What is Axsome Therapeutics annual depreciation & amortization?
The current annual D&A of AXSM is $6.83 M
What is the all time high annual D&A for Axsome Therapeutics?
Axsome Therapeutics all-time high annual depreciation & amortization is $6.83 M
What is Axsome Therapeutics annual D&A year-on-year change?
Over the past year, AXSM annual depreciation & amortization has changed by +$2.43 M (+55.25%)
What is Axsome Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of AXSM is $2.06 M
What is the all time high quarterly D&A for Axsome Therapeutics?
Axsome Therapeutics all-time high quarterly depreciation & amortization is $2.06 M
What is Axsome Therapeutics quarterly D&A year-on-year change?
Over the past year, AXSM quarterly depreciation & amortization has changed by +$321.00 K (+18.45%)
What is Axsome Therapeutics TTM depreciation & amortization?
The current TTM D&A of AXSM is $7.63 M
What is the all time high TTM D&A for Axsome Therapeutics?
Axsome Therapeutics all-time high TTM depreciation & amortization is $7.63 M
What is Axsome Therapeutics TTM D&A year-on-year change?
Over the past year, AXSM TTM depreciation & amortization has changed by +$791.00 K (+11.57%)